CN Patent
CN103154245B — 反义核酸
Assigned to Nippon Shinyaku Co Ltd · Expires 2016-06-01 · 10y expired
What this patent protects
本发明的目的是提供能够高效地使人抗肌萎缩蛋白基因的第53号外显子发生跳跃的药剂。本发明提供能够使人抗肌萎缩蛋白基因的第53号外显子发生跳跃的寡聚物。
USPTO Abstract
本发明的目的是提供能够高效地使人抗肌萎缩蛋白基因的第53号外显子发生跳跃的药剂。本发明提供能够使人抗肌萎缩蛋白基因的第53号外显子发生跳跃的寡聚物。
Drugs covered by this patent
- Viltepso (VILTOLARSEN) · Nippon Shinyaku
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.